TOP 30 Medical research and development in New York City, New York

Radiation Oncology at Mount Sinai West is a leading medical institution located at 1000 10th Avenue in New York, New York, United States. Specializing in cancer treatment using advanced radiation therapy techniques, our team of experienced doctors and healthcare professionals are dedicated to providing personalized care and support to patients throughout their journey. With state-of-the-art technology and a multidisciplinary approach, we strive to deliver the highest quality of care in a compassionate and comfortable environment. Trust in Radiation Oncology at Mount Sinai West for expert cancer treatment and exceptional patient care.

Anna M. Varghese, MD is a highly specialized MSK Gastrointestinal Oncologist located at 1275 York Avenue in New York, New York, United States. The institution is dedicated to changing how the world understands and treats cancer through cutting-edge research and advanced treatments. Dr. Varghese is a board-certified medical oncologist with expertise in cancers of unknown primary and gastrointestinal cancers, including pancreas, colorectal, and biliary cancers. She collaborates with a multidisciplinary team to provide personalized care for each patient. The institution offers outpatient care and is committed to providing the best treatment options for patients with various types of cancer. Dr. Varghese's research focuses on developing better treatment strategies for pancreas cancer, colorectal cancer, and cancers of unknown primary. As a gastrointestinal oncologist, she specializes in anal, colorectal, esophageal, gastric, liver, and pancreatic cancers, as well as GI stromal tumors and neuroendocrine tumors.

Neil M. Iyengar, MD - MSK Breast Oncologist is a leading institution located at 300 East 66th Street in New York, New York, United States. They are dedicated to changing how the world understands and treats cancer through cutting-edge research and innovative treatments. As a medical oncologist and clinical investigator, Dr. Iyengar specializes in the care of patients with breast cancer, providing individualized and multifaceted treatment plans based on the latest research. The institution offers state-of-the-art care plans using advanced technologies and strategies, as well as support for general well-being. Dr. Iyengar's research focuses on the links between metabolic health and cancer, with a goal of preventing obesity-related cancers and improving outcomes for patients. Patients can expect clear communication and information about standard therapies and research options to empower them to make informed decisions about their care. The institution also offers financial assistance programs for those without health insurance or concerned about coverage. With a team of specialists from various areas, including nurse practitioner Odessa M. Williams, Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer and running numerous clinical trials. Patients can participate in clinical trials even if they are new to MSK. The institution values transparency and requires doctors and faculty members to disclose any relationships and financial interests with external entities. They also offer support in understanding insurance options and coverage. Memorial Sloan Kettering is committed to providing trustworthy, honest, and fair reviews to ensure the best patient experience.

Gulam A. Manji, MD is a renowned medical institution located at 161 Fort Washington Avenue in New York, United States. Dr. Manji is an Assistant Professor of Medicine at Columbia University Medical Center, specializing in the treatment of gastrointestinal malignancies, melanoma, and sarcoma. With a focus on developing new cancer treatments, Dr. Manji conducts translational research and has received recognition for his work in preclinical combination immunotherapy studies. In addition to his research, Dr. Manji also provides care for patients with gastrointestinal malignancies, with a particular emphasis on pancreatic and liver cancers, and sarcomas. He is actively involved in conducting clinical trials for various types of cancers, including liver, bile duct, gallbladder, and pancreas cancers. Dr. Manji's dedication to advancing cancer treatment and his expertise in the field make him a trusted and respected physician in the medical community.

Susan E. Bates, MD is a renowned institution located at 161 Fort Washington Avenue in New York, New York, United States. Dr. Susan Bates, the founder, is a highly respected medical professional with a background in internal medicine and medical oncology. She has led groundbreaking research in multidrug resistance and epigenetic modifying agents, contributing significantly to the field of oncology. At Susan E. Bates, MD, the focus is on both laboratory and clinical research, with a special interest in drug resistance in T-cell lymphomas and advanced solid tumors. Dr. Bates is dedicated to developing new antineoplastic agents and exploring combination therapies to improve treatment options for difficult-to-treat cancers.

Alexander N. Shoushtari, MD - MSK Melanoma Oncologist & Cellular Therapist is a renowned institution located at 1275 York Avenue, New York, New York, United States. The institution is dedicated to changing the way cancer is understood and treated, with a focus on melanoma. Their team of scientists conducts cutting-edge research in various aspects of cancer, from genetics to immune-based treatments. They also offer specialized educational programs to train the next generation of cancer care leaders. Operating Monday through Friday, their expert team provides comprehensive care and support for all types of cancer, with a special emphasis on melanoma. Dr. Shoushtari, a board-certified medical oncologist, leads the Melanoma Service and is known for his expertise in treating rare types of melanoma such as acral, mucosal, and uveal melanomas. He works closely with a multidisciplinary team to provide personalized care and access to innovative treatment options.

Leonard Saltz, MD - MSK Gastrointestinal Oncologist is a renowned institution located at 1275 York Avenue, New York, United States. They are dedicated to changing the way the world understands and treats cancer, with a focus on gastrointestinal cancers. The institution offers highly specialized educational programs to train the next generation of clinicians and scientists in the field of oncology. The experts at Leonard Saltz, MD - MSK Gastrointestinal Oncologist provide comprehensive care and support for all types of cancer, including rare gastrointestinal tumors. They are leaders in cancer research, constantly developing new treatments and therapies for colorectal and other gastrointestinal cancers. Dr. Leonard Saltz, the head of the institution, has treated thousands of patients with gastrointestinal cancers over the years. He has expertise in managing cancers of the colon, rectum, liver, pancreas, stomach, esophagus, and other digestive tract cancers. Dr. Saltz is also actively involved in developing new drug therapies and treatment strategies for colorectal cancer, utilizing the resources of Memorial Sloan Kettering Cancer Center to create an integrated translational research program.

Geoffrey Y. Ku, MD - MSK Gastrointestinal Oncologist & Cellular Therapist is a leading institution located at 1275 York Avenue, New York, United States. Specializing in the treatment of gastrointestinal cancers, the institution is dedicated to changing how cancer is understood and treated. With a team of highly specialized professionals, including Dr. Ku, the institution offers innovative treatments such as cellular therapy, immunotherapy, and targeted therapies. Dr. Ku's research focuses on developing new treatments for esophageal and gastric cancers, with a particular interest in combining chemotherapy and radiation therapy. As Head of the Esophagogastric Section in the Gastrointestinal Oncology Service, Dr. Ku is at the forefront of cancer care and research. The institution's commitment to providing expert cancer care is evident in their personalized approach to treating each patient as an individual. Additionally, the institution offers financial assistance programs to ensure that all patients receive the care they need. With a focus on transparency, the institution discloses any relationships or financial interests with external entities. For patients seeking more information about their doctor's external relationships, they are encouraged to speak with their healthcare provider.

David Paul Kelsen, MD is a renowned MSK Gastrointestinal Oncologist located at 1275 York Avenue in New York, United States. The institution is dedicated to changing the way the world understands and treats cancer, with a focus on exploring every aspect of cancer research. The institution offers specialized educational programs to train the next generation of clinicians and scientists in the field of cancer care and research. Operating Monday through Friday from 8 a.m. to 6 p.m. Eastern time, the institution provides comprehensive care for all types of cancer, including gastrointestinal malignancies. Dr. Kelsen is a board-certified medical oncologist with clinical and research interests in gastrointestinal cancers, neuroendocrine tumors, and cancers of unknown primary site. His research focuses on upper gastrointestinal cancers, particularly pancreatic and gastroesophageal cancers. Dr. Kelsen has served on various national committees related to cancer research and is currently the co-chair of the Clinical Trials subcommittee of the Lustgarten Foundation for Pancreatic Cancer Research. The institution works with a variety of insurance providers and offers financial assistance programs for patients in need. Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer and running numerous clinical trials. Patients can find more information about Dr. Kelsen's research and publications on PubMed. The institution is committed to transparency and discloses all relationships and financial interests with external entities. Patients can contact MSK's Compliance Office for more information on the institution's COI-related policies and procedures.

Wungki Park, MD, MS is a leading MSK Gastrointestinal Oncologist located at 160 East 53rd Street, New York, New York, United States. The institution is dedicated to changing how the world understands and treats cancer, with a team of experts specializing in various areas of cancer care. Dr. Park focuses on cancers of the pancreas and bile system, working closely with a multidisciplinary team to provide the best care for patients and their families. The institution offers outpatient services and has relationships with many common healthcare providers and plans. Dr. Park's research focuses on immunotherapy and developing new strategies for cancer treatment through clinical trials. Patients can participate in clinical trials at MSK, and the institution is constantly developing new treatments for cancer. Transparency is a priority at MSK, with doctors and faculty members disclosing their relationships with external entities. For more information on MSK's COI policies, patients can contact the Compliance Office.

Rachel Sanford, MD is a highly specialized breast oncologist located at 1275 York Avenue in New York, New York, United States. Dr. Sanford is dedicated to changing the way cancer is understood and treated, offering comprehensive care and support to patients with all types of cancer, with a focus on breast cancer. She is board-certified and practices evidence-based medicine, incorporating the latest research findings into personalized treatment plans for each individual patient. Dr. Sanford works closely with a team of experts at Memorial Sloan Kettering, a world-renowned institution for cancer care, research, and education. She is committed to ensuring her patients have access to cutting-edge treatments, including clinical trials, and provides clear and compassionate communication throughout the treatment process. Dr. Sanford's research interests include neoadjuvant chemotherapy for certain types of breast cancer, providing valuable prognostic information for patients.

Julia Brockway-Marchello, MD is a highly specialized MSK breast oncologist located at 1275 York Avenue in New York, United States. The institution is dedicated to changing the way cancer is understood and treated, with a team of scientists conducting research in various aspects of cancer biology and treatment. The institution offers comprehensive care for all types of cancer, including breast cancer. Dr. Brockway-Marchello is committed to providing compassionate care for her patients, from diagnosis through treatment and survivorship. She works closely with her patients to make informed decisions about their treatment plans, ensuring they feel supported and confident throughout their journey. As a breast oncologist, she specializes in breast cancer survivorship, quality-of-life issues, and palliative care.

Leno Thomas is a reputable healthcare institution located at 400 Westage Business Center Drive in Fishkill, New York, United States. Specializing in providing top-quality medical care, Leno Thomas offers a range of services to help patients maintain and improve their health. With a team of skilled doctors and healthcare professionals, the institution is dedicated to providing personalized and compassionate care to all patients. Whether you are in need of routine check-ups, specialized treatments, or preventative care, Leno Thomas is committed to helping you achieve optimal health and wellness. Visit Leno Thomas for all your healthcare needs and experience top-notch medical care in a welcoming and professional environment.

Dr. Saad Yousuf is a reputable healthcare institution located at 600 Westage Business Center Drive in Fishkill, New York. Specializing in providing top-quality medical care, Dr. Yousuf and his team are dedicated to serving the community with compassion and expertise. Patients can expect personalized treatment plans, state-of-the-art facilities, and a commitment to promoting overall health and well-being. Whether you are in need of routine check-ups, specialized treatments, or preventive care, Dr. Saad Yousuf is here to help you achieve optimal health.

Tanya M. Trippett, MD is a highly specialized MSK Pediatric Hematologist-Oncologist located at 1275 York Avenue in New York, United States. She is dedicated to changing the way cancer is understood and treated, with a focus on pediatric leukemia and lymphoma. Dr. Trippett conducts clinical research to develop new therapies for children with cancer, and has a background in molecular pharmacology and translational research. She is also involved in global initiatives to improve cancer care for children in limited resource nations. As a member of the MSK Kids team, Dr. Trippett provides expert care for children with all types of cancer, including those that have returned despite prior treatment. She is involved in educational programs to train the next generation of clinicians and scientists in the field of pediatric oncology.

Martee L. Hensley, MD is a renowned MSK Gynecologic Oncologist located at 1275 York Avenue in New York, United States. Dr. Hensley and his team are dedicated to changing how the world understands and treats cancer, offering specialized care for women with gynecologic cancers. With expertise in treating uterine sarcomas, Dr. Hensley is committed to developing novel treatments and improving strategies for patients with recurrent ovarian cancer or uterine sarcomas. As a board-certified medical oncologist, Dr. Hensley has been at Memorial Sloan Kettering Cancer Center since 1998, working alongside a multidisciplinary team to provide comprehensive care for women with gynecologic cancers. In addition to his clinical practice, Dr. Hensley is actively involved in research and serves as principal investigator for national and international studies in the field. Patients can expect personalized care and support from diagnosis to treatment at this world-leading institution. Operating Monday through Friday, Memorial Sloan Kettering Cancer Center is dedicated to training the next generation of clinicians and scientists, shaping leaders in cancer care and research. With a focus on patient-centered care, Dr. Hensley and his team aim to provide the best possible outcomes for every individual.

Lauren Schaff, MD is a renowned MSK Neurologist & Neuro-Oncologist located at 1275 York Avenue, New York, United States. The institution is dedicated to changing how the world understands and treats cancer, offering specialized care for all types of cancer, including primary brain tumors. The highly-specialized educational programs shape leaders in the field of cancer care and research. With operating hours from Monday to Friday, the institution provides comprehensive care and support to patients and their caregivers. The team of experts at Memorial Sloan Kettering is committed to staying on the cutting edge of cancer therapeutics while providing reassurance to patients. Dr. Schaff specializes in treating primary brain tumors and central nervous system tumors, working with a team of physicians, nurses, researchers, and administrative staff to provide the best possible care. The institution has relationships with many common healthcare providers and plans, offering financial assistance programs for those in need. Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer, with hundreds of clinical trials running at any given time. Patients may be able to participate in a clinical trial, even if they are new to MSK. Dr. Schaff's journal articles can be found on PubMed, and the institution is committed to transparency regarding external relationships and financial interests. For more information about their COI policies, patients can contact MSK's Compliance Office.

Dawn L Hershman, MD, MS, FASCO is a renowned institution located at 161 Fort Washington Avenue in New York, New York, United States. Dr. Hershman is an American Cancer Society Professor of Medicine and Epidemiology, as well as the Director of Breast Oncology and co-leader of the Cancer Population Science program at the Herbert Irving Comprehensive Cancer Center at Columbia University. With a medical degree from the Albert Einstein College of Medicine and fellowship training at Columbia University Medical Center, Dr. Hershman has established herself as an expert in breast cancer treatment, prevention, and survivorship. She has received funding from various prestigious organizations and has mentored numerous faculty members in their career development.

Nicole Lamanna, MD, located at 161 Fort Washington Avenue in New York, is an institution specializing in hematology and oncology. Dr. Lamanna is an Associate Clinical Professor of Medicine with a focus on lymphoid leukemias, particularly chronic lymphocytic leukemia. With a background in clinical research, she is dedicated to developing innovative combination therapies using chemoimmunotherapy, immunomodulatory drugs, kinase inhibitors, and monoclonal antibodies. Dr. Lamanna is committed to finding effective and safer treatment options for older patients with these conditions. She obtained her medical degree from Albert Einstein College of Medicine and completed her fellowship in Hematology-Oncology at Memorial Sloan-Kettering Cancer Center.

Matthew A. Ingham, MD is a renowned institution located at 161 Fort Washington Avenue in New York, New York, United States. Dr. Ingham is an Assistant Professor of Medicine specializing in Hematology and Oncology at New York Presbyterian Hospital/Columbia University Medical Center. He received his medical degree from the University of Massachusetts Medical School and has completed extensive training in Internal Medicine and Hematology/Medical Oncology. Dr. Ingham's expertise lies in the treatment of patients with sarcoma and gastrointestinal cancers, and he is actively involved in research to develop and evaluate new treatment options for sarcoma patients. He is currently leading clinical trials sponsored by the National Cancer Institute (NCI) to study innovative approaches for uterine leiomyosarcoma and other types of sarcoma.

Charles G. Drake, MD, PhD is a renowned physician-scientist located at 161 Fort Washington Avenue in New York, New York, United States. Dr. Drake's work focuses on understanding and combatting advanced-stage cancers using the immune system. He is known for quickly translating research discoveries into cutting-edge clinical trials, including the development of anti-tumor vaccines. His laboratory was the first to identify Lymphocyte Activation Gene-3 (LAG-3) as a marker for regulatory CD4 cells and to show that blocking LAG-3 can enhance anti-tumor immune responses. Dr. Drake's research has been published in prestigious journals and he has held positions at Johns Hopkins Kimmel Cancer Center. He is a professor of oncology, urology, and immunology, and has developed innovative models for studying prostate cancer. Dr. Drake earned his MD and PhD from top institutions and completed his medical training at Johns Hopkins Hospital. His work continues to push the boundaries of cancer treatment by exploring the intersection of immunotherapy and radiation therapy.

Antonio Tito Fojo, MD is a renowned doctor and health institution located at 161 Fort Washington Avenue in New York, New York, United States. Dr. Fojo received his MD and PhD from the University of Miami and has extensive experience in internal medicine, particularly in the field of oncology. As a Principal Investigator at the National Cancer Institute, Dr. Fojo has established a successful translational clinical program focused on developing novel therapies for endocrine and neuroendocrine cancers. He specializes in the management of patients with adrenocortical cancer, malignant pheochromocytoma, thyroid cancer, and other neuroendocrine malignancies.

Ryan H. Moy, MD, PhD is a prestigious medical institution located in New York, New York, United States. Dr. Ryan Moy is an Assistant Professor of Medicine and medical oncologist at Columbia University Irving Medical Center, specializing in the treatment of gastrointestinal malignancies, particularly esophageal and stomach cancers. With a background in MD/PhD from the University of Pennsylvania and training from top medical centers such as NewYork-Presbyterian Hospital/Weill Cornell Medical Center and Memorial Sloan Kettering Cancer Center, Dr. Moy is a leading expert in his field. Dr. Moy is actively involved in translational research, focusing on understanding the biological mechanisms that drive metastasis in gastrointestinal cancers. His research has led to important discoveries in genes promoting liver metastasis in colorectal cancer, as well as identifying vulnerabilities in esophageal and gastric cancers. Dr. Moy is committed to translating these findings into more effective treatments for his patients, leading clinical trials investigating targeted and immunotherapy treatments for esophagogastric cancer and other malignancies.

Salvador Alonso Martinez, MD - MSK Gynecologic Oncologist is a renowned institution located at 160 East 53rd Street, New York, New York, United States. This institution is dedicated to changing the way cancer is understood and treated, with a focus on gynecologic cancers. The team of experts at this institution conducts cutting-edge research on cancer biology, develops innovative treatments, and trains the next generation of clinicians and scientists. Operating Monday through Friday from 8 a.m. to 6 p.m. (Eastern time), they provide comprehensive care and support to patients facing all types of cancer. Dr. Salvador Alonso Martinez is a medical oncologist and physician-scientist specializing in gynecologic cancers. He is committed to providing compassionate and individualized care to his patients, empowering them with information about their disease and treatment options. Dr. Martinez also conducts research to understand and overcome resistance to existing therapies, with the goal of transforming cancer into a manageable condition. Patients can benefit from participating in clinical trials, where they may have access to cutting-edge treatments.

Nobuko Hijiya, MD is a renowned institution located at 161 Fort Washington Avenue in New York, specializing in pediatric hematology and oncology. Dr. Hijiya has a particular focus on leukemias and lymphomas, providing expert care for children, adolescents, and young adults. With a passion for personalized medicine, Dr. Hijiya works closely with each patient to tailor treatments based on their unique needs. As a leader in the field, Dr. Hijiya is actively involved in research on pediatric leukemias and lymphomas, exploring new treatments and collaborating with researchers to develop innovative therapies. In addition to her clinical work, Dr. Hijiya is dedicated to educating and mentoring the next generation of pediatric hematology/oncology professionals.

Justine Kahn, MD is a renowned Pediatric Oncologist located at 161 Fort Washington Avenue in New York, New York, United States. Dr. Kahn specializes in survival outcomes, cancer care delivery, and health equity for children and adolescent/young adults with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). She received her MD from the Icahn School of Medicine at Mount Sinai and completed her Pediatric Residency at Mount Sinai Kravis Children's Hospital. Dr. Kahn also completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. Dr. Kahn is dedicated to patient care, clinical trials research, and health outcomes research. She is actively involved in research studies through the Dana-Farber Cancer Institute ALL Consortium, Children's Oncology Group, and Columbia University. Her focus on underserved populations stems from the belief that poor access-to-care, low health literacy, and financial stress can impact survival rates in children and AYAs with cancer.

Advanced Oncology Associates is a leading oncology practice located at 1695 Eastchester Road in New York, United States. Our team of dedicated doctors specializes in providing comprehensive care for patients with cancer. From diagnosis to treatment and survivorship, we are committed to offering the most advanced and personalized care to our patients. Our state-of-the-art facility is equipped with the latest technology and our team of experts are constantly staying up-to-date with the latest advancements in oncology research and treatment. At Advanced Oncology Associates, we strive to provide compassionate and individualized care to each and every patient, helping them navigate their cancer journey with confidence and support.

Markus Y Mapara, MD is a renowned institution located at 161 Fort Washington Avenue in New York, New York, United States. Dr. Mapara is a Professor of Medicine at Columbia University Medical Center and serves as the Director of the Blood and Marrow Transplantation (BMT)/Cell Therapy Program at New York Presbyterian Hospital/Columbia University Medical Center. Dr. Mapara graduated from the University of Heidelberg Medical School in Germany and completed his post-graduate training in Internal Medicine and Hematology/Oncology at prestigious institutions in Germany and the United States. He has extensive experience in the field of bone marrow transplantation and gene therapy, specializing in the care of patients with sickle cell disease and certain blood cancers such as Multiple Myeloma and Amyloidosis.

Rachel N. Grisham, MD is a renowned MSK Gynecologic Oncologist located at 1275 York Avenue, New York, New York, United States. Dr. Grisham is dedicated to changing the way the world understands and treats cancer, with a focus on gynecologic malignancies such as ovarian, uterine, and cervical cancers. She is a medical oncologist with expertise in developing novel treatments and improving treatment strategies for women with gynecologic cancers. Dr. Grisham is also actively involved in clinical research and serves as the principal investigator for ongoing clinical trials in this field. Memorial Sloan Kettering, where Dr. Grisham practices, is a world leader in patient care, research, and educational programs. The institution offers comprehensive cancer care and support for all types of cancer, with a team of specialists working together to provide the best possible care for each patient. MSK offers financial assistance programs for those without health insurance or worried about coverage.

Ruth Oratz, MD is a leading institution located at 160 East 34th Street, New York, New York, United States. Specializing in providing the highest quality of care and expertise in all specialty care areas, Dr. Oratz and her team offer a range of imaging services from CT and MRI scans to ultrasound and X-ray throughout the New York City area. Patients can learn about the institution's approach to diagnosing and treating adults and children, as well as access support services before, during, and after their visit. As a medical oncologist, Dr. Oratz focuses on treating individuals with all stages of breast cancer, as well as those at an increased risk of developing cancer. She is dedicated to providing a positive experience for her patients and emphasizes overall wellness in her treatment approach, including diet, exercise, and lifestyle recommendations. Dr. Oratz is actively involved in breast cancer clinical trials and has a particular interest in caring for individuals with genetic mutations like BRCA.